Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 54

1.

Metabolic Engineering of Yeast for the Production of 3-Hydroxypropionic Acid.

Ji RY, Ding Y, Shi TQ, Lin L, Huang H, Gao Z, Ji XJ.

Front Microbiol. 2018 Sep 20;9:2185. doi: 10.3389/fmicb.2018.02185. eCollection 2018. Review.

2.

Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE): an international observational study.

Langhorne P, O'Donnell MJ, Chin SL, Zhang H, Xavier D, Avezum A, Mathur N, Turner M, MacLeod MJ, Lopez-Jaramillo P, Damasceno A, Hankey GJ, Dans AL, Elsayed A, Mondo C, Wasay M, Czlonkowska A, Weimar C, Yusufali AH, Hussain FA, Lisheng L, Diener HC, Ryglewicz D, Pogosova N, Iqbal R, Diaz R, Yusoff K, Oguz A, Wang X, Penaherrera E, Lanas F, Ogah OS, Ogunniyi A, Iversen HK, Malaga G, Rumboldt Z, Magazi D, Nilanont Y, Rosengren A, Oveisgharan S, Yusuf S; INTERSTROKE collaborators.

Lancet. 2018 May 19;391(10134):2019-2027. doi: 10.1016/S0140-6736(18)30802-X. Epub 2018 May 17.

PMID:
29864018
3.

CRISPR/Cas9-based genome editing of the filamentous fungi: the state of the art.

Shi TQ, Liu GN, Ji RY, Shi K, Song P, Ren LJ, Huang H, Ji XJ.

Appl Microbiol Biotechnol. 2017 Oct;101(20):7435-7443. doi: 10.1007/s00253-017-8497-9. Epub 2017 Sep 8. Review.

PMID:
28887634
4.

Microbial production of plant hormones: Opportunities and challenges.

Shi TQ, Peng H, Zeng SY, Ji RY, Shi K, Huang H, Ji XJ.

Bioengineered. 2017 Mar 4;8(2):124-128. doi: 10.1080/21655979.2016.1212138. Epub 2016 Jul 26.

5.

[Design and synthesis of a type of benzopyran derivatives with insulin-sensitizing activity].

Tang L, Li Y, Yu JH, Yang YS, Ji RY.

Yao Xue Xue Bao. 2008 Jun;43(6):605-10. Chinese.

PMID:
18822963
6.

[Design, synthesis and anti-HBV activity of L-amino acid ester prodrugs of acyclic nucleoside phosphonates].

Fu XZ, Jiang SH, Yang YS, Ji RY.

Yao Xue Xue Bao. 2008 May;43(5):495-503. Chinese.

PMID:
18717337
7.

[Synthesis and biological activity of a series of benzopyran derivatives].

Tang L, Yang YS, Ji RY.

Yao Xue Xue Bao. 2008 Feb;43(2):162-8. Chinese.

PMID:
18507343
8.

Insulin-sensitizing effects of a novel alpha-methyl- alpha -phenoxylpropionate derivative in vitro.

Wu HS, Yu JH, Li YY, Yang YS, He QJ, Lou YJ, Ji RY.

Acta Pharmacol Sin. 2007 Mar;28(3):417-22.

9.

[Design, synthesis and insulin-sensitizing activity of indole derivatives].

Tang L, Yang YS, Ji RY.

Yao Xue Xue Bao. 2006 Mar;41(3):225-9. Chinese.

PMID:
16758992
10.

[Progress in studies on antidiabetic agents].

Tang L, Yang YS, Ji RY.

Yao Xue Xue Bao. 2001 Sep;36(9):711-5. Review. Chinese. No abstract available.

PMID:
12580115
11.

[Recent development in quinolone compounds antitumor quinolones].

Yang YS, Zhao SR, Ji RY, Chen KX.

Yao Xue Xue Bao. 1998;33(2):157-60. Review. Chinese. No abstract available.

PMID:
11938953
12.

A density-functional study of the mechanism for the diastereoselective epoxidation of chiral allylic alcohols by the titanium peroxy complexes.

Cui M, Adam W, Shen JH, Luo XM, Tan XJ, Chen KX, Ji RY, Jiang HL.

J Org Chem. 2002 Mar 8;67(5):1427-35.

PMID:
11871869
13.

A 3D structural model of memapsin 2 protease generated from theoretical study.

Huang XQ, Jiang HL, Luo XM, Shen JK, Chen KX, Ji RY, Cao Y, Xue H.

Acta Pharmacol Sin. 2001 Jan;22(1):50-6.

14.

Study on mechanism of interaction of nociceptin and opioids binding with opioid receptor-like 1 receptor.

Huang XQ, Jiang HL, Luo XM, Chen KX, Zhu YC, Ji RY, Cao Y.

Acta Pharmacol Sin. 2000 Jun;21(6):536-46.

15.

Comparative molecular modeling on 3D-structure of opioid receptor-like 1 receptor.

Huang XQ, Jiang HL, Luo XM, Chen KX, Zhu YC, Ji RY, Cao Y.

Acta Pharmacol Sin. 2000 Jun;21(6):529-35.

16.

Building three-dimensional structures of HIV-1 coreceptor CCR5 and its interaction with antagonist TAK779 by comparative molecular modeling.

Huang XQ, Jiang HL, Luo XM, Chen KX, Ji RY, Cao Y, Pei G.

Acta Pharmacol Sin. 2000 Jun;21(6):521-8.

18.

Molecular modeling on solvent effect and interaction mechanism of fentanyl analogs to mu-opioid receptor.

Huang XQ, Jiang HL, Luo XM, Rong SB, Gu JD, Tan XJ, Zhu YC, Chen KX, Ji RY, Cao Y.

Acta Pharmacol Sin. 2000 Jan;21(1):46-54.

19.

Molecular modeling on kappa opioid receptor and its interaction with nonpeptide kappa opioid agonists.

Liu DX, Jiang HL, Shen JS, Zhu WL, Zhao L, Chen KX, Ji RY.

Zhongguo Yao Li Xue Bao. 1999 Feb;20(2):131-6.

20.

Establishment of kappa opioid receptor agonists pharmacophore with molecular modeling method.

Liu DX, Tang Y, Jiang HL, Chen KX, Ji RY.

Zhongguo Yao Li Xue Bao. 1998 Sep;19(5):445-50.

Supplemental Content

Loading ...
Support Center